ArticleCancer medicine2021

Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study.

Tressie Herrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.